KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amneal Pharmaceuticals (AMRX) EPS (Weighted Average and Diluted): 2018-2025

Historic EPS (Weighted Average and Diluted) for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Sep 2025 value amounting to $0.01.

  • Amneal Pharmaceuticals' EPS (Weighted Average and Diluted) fell 73.66% to $0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.02, marking a year-over-year increase of 102.46%. This contributed to the annual value of -$0.38 for FY2024, which is 20.83% up from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported EPS (Weighted Average and Diluted) of $0.01 as of Q3 2025, which was down 85.71% from $0.07 recorded in Q2 2025.
  • Amneal Pharmaceuticals' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.10 during Q2 2021, with a 5-year trough of -$0.80 in Q2 2022.
  • In the last 3 years, Amneal Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of $0.02 in 2024 and averaged -$0.06.
  • Within the past 5 years, the most significant YoY rise in Amneal Pharmaceuticals' EPS (Weighted Average and Diluted) was 400.00% (2023), while the steepest drop was 1,800.00% (2023).
  • Quarterly analysis of 5 years shows Amneal Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.04 in 2021, then grew by 25.00% to -$0.03 in 2022, then plummeted by 1,800.00% to -$0.57 in 2023, then surged by 82.46% to -$0.10 in 2024, then crashed by 73.66% to $0.01 in 2025.
  • Its last three reported values are $0.01 in Q3 2025, $0.07 for Q2 2025, and $0.04 during Q1 2025.